NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified and
transduced with a lentiviral vector expressing a chimeric antigen receptor (CAR) targeting
the tumor-associated antigen (TAA) CD19 and containing, as of yet undisclosed co-stimulatory
signaling domains, with potential immunostimulating and antineoplastic activities.
Upon administration, autologous anti-CD19 CAR T-cells IM19 target and bind to CD19-expressing
tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19
antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage
malignancies.;